X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TEVA PHARMA (Israel) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
TEVA PHARMA
Dec-13
ALEMBIC LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs722,929-   
Low Rs342,545-   
Sales per share (Unadj.) Rs4.71,681.2-  
Earnings per share (Unadj.) Rs6.1105.0-  
Cash flow per share (Unadj.) Rs6.2240.9-  
Dividends per share (Unadj.) Rs0.2091.94-  
Dividend yield (eoy) %0.43.4 11.2%  
Book value per share (Unadj.) Rs40.71,867.5-  
Shares outstanding (eoy) m267.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.6 691.9%   
Avg P/E ratio x8.726.1 33.3%  
P/CF ratio (eoy) x8.511.4 74.6%  
Price / Book Value ratio x1.31.5 88.9%  
Dividend payout %3.387.5 3.7%   
Avg Mkt Cap Rs m14,1392,320,993 0.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM31,719.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,981.5-  
INCOME DATA
Net Sales Rs m1,2551,425,637 0.1%  
Other income Rs m3700-   
Total revenues Rs m1,6251,425,637 0.1%   
Gross profit Rs m111390,411 0.0%  
Depreciation Rs m38115,236 0.0%   
Interest Rs m228,002 0.0%   
Profit before tax Rs m442247,174 0.2%   
Minority Interest Rs m01,123 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-162,256 0.0%   
Tax Rs m24-3,018 -0.8%   
Profit after tax Rs m1,63089,058 1.8%  
Gross profit margin %8.927.4 32.3%  
Effective tax rate %5.4-1.2 -444.0%   
Net profit margin %129.86.2 2,078.6%  
BALANCE SHEET DATA
Current assets Rs m1,867962,870 0.2%   
Current liabilities Rs m591839,704 0.1%   
Net working cap to sales %101.68.6 1,176.6%  
Current ratio x3.21.1 275.4%  
Inventory Days Days9491 103.8%  
Debtors Days Days7496 76.7%  
Net fixed assets Rs m1,791465,644 0.4%   
Share capital Rs m5343,509 15.2%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,8581,583,612 0.7%   
Long term debt Rs m41728,960 0.0%   
Total assets Rs m11,5913,258,036 0.4%  
Interest coverage x260.99.8 2,654.7%   
Debt to equity ratio x00.5 0.8%  
Sales to assets ratio x0.10.4 24.7%   
Return on assets %14.13.6 391.8%  
Return on equity %15.05.6 266.9%  
Return on capital %15.24.9 308.0%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236227,173 0.1%  
From Investments Rs m-224-80,496 0.3%  
From Financial Activity Rs m-27-272,509 0.0%  
Net Cashflow Rs m-15-125,833 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.18 Rs / USD

Compare ALEMBIC LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALEMBIC LTD With: ELDER PHARMA  AUROBINDO PHARMA  UNICHEM LAB  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 17, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - ASTRAZENECA PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS